Prollenium Medical Technologies Inc.

Prollenium Medical Technologies Inc. is a Canadian medical aesthetics manufacturer headquartered in Aurora, Ontario, with a 70,000 sq ft manufacturing facility in Richmond Hill. Founded in 2002, the company specializes in the research, design, manufacture, and distribution of hyaluronic acid (HA)-based dermal fillers and skincare products. As the only manufacturer in North America offering end-to-end product development and manufacturing in a single location, Prollenium serves a global network of over 80 countries. The company's flagship Revanesse® product line includes advanced HA injectables such as Revanesse® Ultra and Revanesse® Contour. Prollenium also offers VAMP™, a next-generation skin booster for rejuvenation, and skincare products under the Phiderma and Alyria brands. The company holds six patents related to dermal filler technology and is ISO 13485:2016 certified and FDA-approved. Each product undergoes rigorous quality assurance, with individual syringe inspection. Prollenium employs over 150 people and operates the PACE (Prollenium Advanced Clinical Education) program, offering hands-on training, cadaver labs, symposiums, and online education for aesthetic practitioners.